RRM1 and cancer: RRM1, the large catalytic subunit of ribonucleotide reductase responsible for generating deoxynucleoside triphosphates for DNA synthesis, is inhibited by gemcitabine (36), which is used to treat various cancers but whose efficacy in chordoma has not yet been tested.